• Hemostemix granted 6,280,000 stock options on July 22, 2026 to directors, officers, employees, and consultants.
• 4,535,000 options vest immediately; 1,745,000 options vest 50% on July 22, 2026 and 50% on July 22, 2027.
• Directors and officers received 3,140,000 of the options.
• Options outstanding rose to 20,496,694 following the grant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hemostemix Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607221650NEWSFILECNPR____20260722_306143_1) on July 22, 2026, and is solely responsible for the information contained therein.